Table 2.
Virus | Cell/Tissue | Inflammatory Cytokines and Chemokines | Chemokines | References |
---|---|---|---|---|
TBEV | primary human astrocytes | TNF α, IFN α, IL-1β, IL-6, IL-8 | CCL4/MIP-1β, CXCL10 | [9] |
WNV | U373 astrocytic cell line | IL-1β | CXCL10, CCL2 | [139] |
WNV | primary human astrocytes | N/A | CXCL10, CCL5 | [140] |
ZIKV | primary human brain cortical astrocytes | IL-6, IL-8, IL-12, | CXCL-10, CCL5 | [16] |
ZIKV | primary human brain cortical astrocytes | IL-6, IL-1α, IL-4, TGF-β1 | CXCL-10, CCL5 | [10] |
JEV | mouse astrocytes (in situ) | N/A | CXCL10 | [141] |
JEV | primary rat astrocytes | IL-6, TNF-α, IL-1β | CCL5 | [142] |
JEV | primary human astrocytes | IL-6 | CXCL10, CCL2/3/4 | [12] |
JEV | human fetal astrocyte cell line SVG | IL-18, IL-1β | [143] | |
SeV | primary mouse astrocytes | IL-6, TNF-α | N/A | [27] |
RABV | mouse astrocytes (in situ) | IFN-β | N/A | [63] |
SARS-CoV-2 | astrocytes differentiated from hiPSCs | N/A *** | N/A | [32] |
HSV-1 | mouse perivascular astrocytes (in situ) and primary astrocytes | CXCL-1 | [144] | |
HIV-1 | primary human astrocytes **** | IL-6, IL-8 | [145] | |
HIV-1 | primary human fetal astrocytes | TNF-α, IL-6, IL-8 | [146] | |
VSV | primary mouse astrocytes | IL-6, TNF-α, IFN-β | [27,63] | |
EV71 | mouse brain astrocytes, in situ | IL-6 | [23] | |
TEMV | primary human astrocytes | IL-8 | MCP-1 | [25] |
TEMV | mouse astrocytes (in situ) | IFN-β | [63] | |
JHMV ** | spinal cord astrocytes (in situ) | CXCL10 | [147] | |
MHV-A59 * | astrocyte cell line | IL-1α, IL-1β, IL-2, IL-15, IL-13, IL-17 | CXCL10 | [148] |
TLR3 ligation | human astrocytes | IL-6, IFN-α | CXCL-10 | [73] |
hiPSCs, human-induced pluripotent stem cells; N/A, not applicable.* Experimental murine coronavirus, murine coronavirus mouse hepatitis virus A-59 (MHV-A59). ** JHM variant V2.2-1 of mouse hepatitis virus (JHMV). *** Not tested in astrocytes, but TLR3/7 and IL-6 were upregulated in neurons. **** Cells transfected with plasmid encoding HIV-1 Nef.